Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2022-03-18

FDA Approved: WINLEVI — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for WINLEVI (clascoterone) from Sun Pharmaceutical Industries, updating the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Winlevi (clascoterone)

Snippet

SUPPL AP for WINLEVI (CLASCOTERONE)